-
Utility of dual assessment of cyTRBC1 and cyTRBC2 by flow cytometry for identifying clonality in sCD3-negative to dimly expressing T cell
Author: Li, Mingyong; Fu, Jun; Li, Yanxin; Fan, Xiaoming; Zhang, Liuyun; Zhou, Lingjie; Zhang, Jin; Zhang, Juan; Xi, Qian
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01483-1
-
Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: a single-arm, open-label, phase Ia/Ib stud
Author: Yang, Fan; Liu, Rui; Fu, Zhonghua; Guo, Yuelu; Ma, Lixia; Cao, Miaomiao; Deng, Biping; Chang, Alex H.; Wu, Haifeng; Gan, Shilin; Chen, Chen; Ke, Xiaoyan; Hu, Kai
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01476-0
-
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myelom
Author: Kumar, Shaji; Jagannath, Sundar; Weisel, Katja C.; Rosinol, Laura; Leleu, Xavier; Dimopoulos, Meletios-Athanasios; Kastritis, Efstathios; Siegel, David S.; Monge, Jorge; Du, Juan; de la Rubia, Javier; Asensi Canto, Pedro; Lee, Jae Hoon; Mateos, Maria-Victoria; Puertas, Borja; Gozzetti, Alessandro; Dytfeld, Dominik; Ocio, Enrique M.; Blade, Joan; Ozaki, Shuji; Beksac, Meral; Escalante, Fernando; Nagaraj, Madhu; Hassan, Rafla; Bonar, Nicolle; Spin, Paul; Shokoohi, Mostafa; Siddiqui, Muhaimen; Wang, Di; Hou, Kevin; West, Michael E. D.; Hampp, Christian; Green, Jeannette; Humblet, Olivier; Breskin, Alexander; Harnett, James; Ge, Wenzhen; Sobel, Rachel E.; Jalbert, Jessica J.; Kroog, Glenn S.; Rodriguez Lorenc, Karen; Ma, Qiufei; Durie, Brian G. M
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01466-2
-
Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemi
Author: Liu, Ge; Zhou, Yile; Lou, Yinjun; Ai, Hao; Mao, Liping; Wang, Qian; Wu, Hongfei; Tong, Hongyan; Wei, Xudong; Jin, Jie; Wang, Huafeng; Yin, Qingsong
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01460-8
-
Imatinib and nilotinib are equally successful in achieving therapy-free remissio
Author: Cheng, Fang; Wang, Yu; Yang, Yunfan; Du, Xin; Zhu, Yu; Weng, Jianyu; Xu, Na; Huang, Jian; Liu, Zhenfang; Ren, Hongbo; Zhao, Huifang; Zhu, Huanling; Jiang, Qian; Zhang, Yanli; Li, Weiming
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01462-6
-
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26
Author: Wei, Juying; Cai, Qingqing; Zhang, Liling; Zou, Liqun; Li, Zengjun; Zhou, Keshu; Wu, Huijing; Qiu, Lihua; Su, Liping; Ding, Kaiyang; Zhou, Hui; Yu, Li; Li, Fei; Li, Wenyu; Lin, Li'e; Xiao, Qing; Wang, Erhua; Jing, Hongmei; Zheng, Meifang; Zhang, Hongyu; Gao, Yuhuan; Gao, Da; Chen, Lijia; Jin, Jie
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01452-8
-
Anti-PD-1 antibody combined with P-GEMOX chemotherapy versus P-GEMOX chemotherapy with or without autologous stem-cell transplantation for previously untreated advanced natural killer/T cell lymphoma: a retrospective cohort stud
Author: Zou, Qihua; Cao, Yi; Wang, Liang; Li, Wuping; Yin, Qingsong; Wu, Yudan; Jing, Hongmei; Peng, Zhigang; Sun, Xiuhua; Rao, Jun; Chen, Ying; Zhang, Hongyu; Zeng, Dongfeng; Li, Bingzong; Zhao, Ying; Zhang, Xudong; Zhang, Yuchen; Gao, Yan; Bai, Bing; Xia, Yi; Fang, Yu; Chen, Zouxiang; Nie, Man; Fang, Xiaojie; Bai, Shenrui; Huang, Huiqiang; Cai, Qingqing; Cai, Jun
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01459-1
-
Long-term outcomes of autologous stem cell transplantation for AL amyloidosis: a 15-year experience from a Chinese referral center and a comparison of different era
Author: Liu, Mengnan; Guo, Jinzhou; Chen, Wencui; Wu, Xiaomei; Xu, Weiwei; Huang, Xianghua
Journal: BLOOD CANCER JOURNAL. 2026; Vol. 16, Issue 1, pp. -. DOI: 10.1038/s41408-026-01464-4
